Breast Reconstruction in Arkansas
Breast Reconstruction in Arkansas section, includes general infrmation about Breast Reconstruction Procedure, Breast Reconstruction Arkansas Local News, Breast Reconstruction Arkansas Surgeon Locator and other Breast Reconstruction related material.
Breast Reconstruction Procedure
This procedure is designed for women who underwent breast amputation after breast cancer or other conditions. Newer techniques allow the surgeon to create a breast which is very similar to the natural one. The reconstruction can be done during the amputation procedure, or a few months or even a year afterwards.
There are a number of implants: the most widely used are silicon implants which have silicon surface and filling. They come in different sizes and shapes.
Becker implants are made of a thick silicon surface (35%-50%) and a solution filling. The advantage of this implant is the ability to adjust its shape to the woman's body. It can also serve as a skin stretcher. There are also implants with a thin silicon surface and a solution filling, which are less used.
The operation can be divided into 2 main categories: (a) a stretcher is inserted, then replaced with an implant; (b) the reconstruction is made from another body tissue.
The most common reconstruction is performed with a stretcher and an implant. After amputation a balloon (stretcher) is inserted under the skin and chest muscles. It has a special valve which can be filled from outside. The implant is being filled gradually with a special solution, until the skin has sufficiently stretched for inserting the implant. It takes another 3-6 months until the breast has acquired its final shape, then the nipple can be reconstructed as well.
Becker implants: sometimes during amputation the skin can be preserved. That would eliminate the need for a stretcher, and a permanent implant (Becker) can be inserted right away.
The breast can also be reconstructed with body tissue from areas with extra skin and fat, like the tummy, buttocks and back. The tissue being removed is called "a flap". Common sites to acquire the flap are the lower tummy and the lotissimus dorsi muscle from the back.
This procedure can be complicated due to implant infection, a contraction of a surface of an implant, silicon leaks and anesthetic complications.
You'll need to stay in hospital 2-7 days after the surgery, while you may feel pain and weakness for a week or two. Complete recovery may take up to 6 weeks, depending on the surgery. You may have an unusual sensation in the breast that would usually disappear over time. In most cases there could be a slight asymmetry between the breasts, however, most women report a significant improvement in their social life and self esteem.
Other Breast Reconstruction Procedures
All Breast Procedures
Breast Reconstruction Arkansas (current)
Arkansas Breast Lift
Arkansas Breast Implants
Arkansas Implant Removal
Arkansas Armpit Incision
More Arkansas info...
Arkansas Get in Little Rock National Airport, located dead center, is Arkansas' main air terminal. Other airports can be found in Fayetteville, Fort Smith, Texarkana, and Memphis, Tennessee.
Arkansas Understand Arkansas' state motto is "The Natural State" and that tells you a lot. It has great state parks with wilderness comprising broadleaf forests. The northwest boasts the Ozark Mountains while the south and east of the state has flatter land and shows more of its agricultural heritage. The Mississippi River forms the eastern border of the state and gives a great blues music heritage, great country music elsewhere (Johnny Cash was an Arkansan) and folk and bluegrass everywhere. There are wonderful state parks with camping facilities and some with cabins. The Buffalo River has majestic scenery and easy canoe float trips (but go in late spring to be sure there is enough water). The summer is HOT and humid; spring and autumn are wetter but mostly from intermittent heavy rain showers. Winter brings a little snow, but this time of year can still be humid. Spring is tornado season.
The spelling and pronunciation of "Arkansas" (it is always ar-kan-saw) reflect the state's heritage. The name is a French pronunciation of a Siouxan word meaning "land of downriver people" and was prescribed by law in 1881. It is technically still illegal to mispronounce the name (the law contains a clause stating that "the variation ar-KAN-sas is an innovation to be discouraged"), so be careful!
Plastic Surgery News...
- Liver cancer is the fifth most common cancer in the world with a poor prognosis. About three quarters of the cases of liver cancer are found in Southeast Asia, including China, Hong Kong, Taiwan, Korea, India, and Japan. The frequency of liver cancer in Southeast Asia and sub-Saharan Africa is greater than 20 cases per 100,000 population.
- This review examines the evidence on rivaroxaban (Xarelto®), an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism (VTE) in patients undergoing major orthopaedic surgery of the lower limbs. A licence application was submitted to the EMEA in November 2007.
The review notes that limited data from the phase III RECORD studies (available in abstract form only) suggest that:
• Daily oral rivaroxaban 10mg is statistically significantly more effective than subcutaneous (s.c.) enoxaparin 40mg for short term thromboprophylaxis in patients undergoing total knee replacement; the primary endpoint (composite of DVT, non-fatal PE , and all-cause mortality) occurred in 9.6% and 18.9% of patients assigned to rivaroxaban or enoxaparin, respectively (p < 0.001).
• In extended thromboprophylaxis for hip arthroplasty, the same primary endpoint was achieved in 1.1% of rivaroxaban patients vs. 3.7% of those receiving enoxaparin (p < 0.001).
• Rivaroxaban and enoxaparin recipients experienced a similar incidence of major bleeding events, ranging from 0.1% to 0.6%.
No phase III liver function test data are available, but phase II data suggest that increases in liver enzymes seen in rivaroxaban recipients were of a similar order to enoxaparin recipients after 5–9 days of treatment. However caution is required until further information is available regarding safety. The review concludes “should efficacy and safety data prove favourable for oral rivoroxaban, and depending on cost, the drug might be particularly appropriate for those patients undergoing extended thromboprophylaxis after hip surgery. There will be no necessity to monitor patients for heparin-induced thrombocytopenia and a reduction in at home nurse visits may be possible. Hence, staff capacity may be released. Economic decisions concerning rivaroxaban uptake will need to balance the possible increase in drug costs versus the possible benefits that may accrue.”